SCHEMBL8420946

SCHEMBL8420946

N#Cc1cc(NS(=O)(=O)c2ccccc2)c(-c2ccc(F)cc2)nc1OCC1CCCC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 7/20 0.45
MCL1 Q07820 2/20 0.41
BCL2A1 Q16548 2/20 0.41
SCN9A Q15858 3/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PIK3CA P42336 1/20 0.39
KAT6A Q92794 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
MAP2K4 P45985 1/20 0.38
SLC22A12 Q96S37 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8419749 0.99 EDNRA (0.44) EDNRAMCL1BCL2A1SCN9AMEN1
SCHEMBL8421220 0.98 EDNRA (0.45) EDNRAMCL1BCL2A1SCN9AMEN1
SCHEMBL8419444 0.96 EDNRA (0.43) EDNRASCN9AMEN1KMT2ANPSR1
SCHEMBL8423236 0.86 MEN1 (0.48) SCN9AMEN1KMT2ANPSR1GPR55
SCHEMBL8419290 0.85 CNR1 (0.48) MCL1SCN9AMEN1KMT2ANPSR1
SCHEMBL8421502 0.85 CNR1 (0.51) SCN9AMEN1KMT2ANPSR1GPR55
SCHEMBL8423223 0.85 PIK3CA (0.46) SCN9AMEN1KMT2AL3MBTL1PIK3CA
SCHEMBL8419910 0.84 MCL1 (0.44) MCL1BCL2A1SCN9AMEN1KMT2A
SCHEMBL8420124 0.84 ALDH1A1 (0.39) MCL1BCL2A1SCN9AMEN1KMT2A
SCHEMBL8421067 0.84 SQOR (0.45) SCN9AMEN1KMT2ANPSR1GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5916905-A ANTIARTHRITIC AGENTS; ANALGESICS; ANTIPYRETICS G. D. SEARLE & CO. (US) 1999-06-29 US disclosed
US-5686470-A 2, 3-substituted pyridines for the treatment of inflammation WEIER RICHARD M (US) 1997-11-11 US disclosed